Why is GE Healthcare Technologies, Inc. ?
1
High Management Efficiency with a high ROCE of 18.55%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 2.11 times
3
Flat results in Dec 25
- RAW MATERIAL COST(Y) Grown by 6.23% (YoY)
- DEBTORS TURNOVER RATIO(HY) Lowest at 4.47 times
4
With ROCE of 18.08%, it has a attractive valuation with a 2.41 Enterprise value to Capital Employed
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -11.96%, its profits have fallen by -4%
5
High Institutional Holdings at 95.22%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 1.93% over the previous quarter.
6
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -11.96% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to GE Healthcare Technologies, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is GE Healthcare Technologies, Inc. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
GE Healthcare Technologies, Inc.
-11.96%
-0.13
37.13%
S&P 500
18.81%
0.98
19.26%
Quality key factors
Factor
Value
Sales Growth (5y)
3.99%
EBIT Growth (5y)
2.66%
EBIT to Interest (avg)
7.73
Debt to EBITDA (avg)
2.11
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
1.08
Tax Ratio
18.50%
Dividend Payout Ratio
3.08%
Pledged Shares
0
Institutional Holding
95.22%
ROCE (avg)
18.55%
ROE (avg)
26.44%
Valuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
3.17
EV to EBIT
13.31
EV to EBITDA
11.10
EV to Capital Employed
2.41
EV to Sales
1.87
PEG Ratio
NA
Dividend Yield
0.10%
ROCE (Latest)
18.08%
ROE (Latest)
20.79%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Movement
7What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at 57.34 %
INTEREST COVERAGE RATIO(Q)
Highest at 850.41
INVENTORY TURNOVER RATIO(HY)
Highest at 5.96 times
NET SALES(Q)
Highest at USD 5,698 MM
OPERATING PROFIT(Q)
Highest at USD 1,046 MM
-2What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 6.23% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.47 times
Here's what is working for GE Healthcare Technologies, Inc.
Interest Coverage Ratio
Highest at 850.41
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Debt-Equity Ratio
Lowest at 57.34 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Sales
Highest at USD 5,698 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 1,046 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Inventory Turnover Ratio
Highest at 5.96 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for GE Healthcare Technologies, Inc.
Debtors Turnover Ratio
Lowest at 4.47 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 6.23% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






